Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing.
about
Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptaseAntiretroviral resistance during successful therapy of HIV type 1 infection.A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 proteaseHuman immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapyComparison between sequence analysis and a line probe assay for testing genotypic resistance of human immunodeficiency virus type 1 to antiretroviral drugs.Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.Novel two-round phenotypic assay for protease inhibitor susceptibility testing of recombinant and primary HIV-1 isolates.Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein.In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure.Evidence for preferential genotyping of a minority human immunodeficiency virus population due to primer-template mismatching during PCR-based amplification.Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation.Novel method for simultaneous quantification of phenotypic resistance to maturation, protease, reverse transcriptase, and integrase HIV inhibitors based on 3'Gag(p2/p7/p1/p6)/PR/RT/INT-recombinant viruses: a useful tool in the multitarget era of antRelative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region.
P2860
Q24550959-55586B53-F079-4408-B3DC-C37D54DC1642Q33919308-5AED2A95-DC04-4374-84F2-37FE88405D48Q33979321-256CA317-8223-435B-822B-A5CFD60D92C3Q33980528-02C5EE04-46D0-4FD4-81AD-50EEBC43F5C3Q34041782-67183DF0-DCB9-496A-8E74-948A003569D5Q35947590-F51860D4-6F09-4FA0-AB42-3BFC947D975AQ36414162-0CCF9264-658B-4708-8079-E5549FCBB4B7Q37033282-DF20B70B-3FD1-4439-8A08-FEC6BF124A19Q39463811-5CD4C03B-32AE-4E71-A0DB-6464148A43F1Q40769991-657F5753-61E0-47C2-94EE-6953D095955BQ41766427-06C70110-78C3-4821-9FC1-180349DF0ECEQ42148219-D817F74E-8C91-4545-8F47-6BCDB5303F6BQ42737965-F887F035-18FE-48F2-8D58-2025185FCA51
P2860
Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Human immunodeficiency virus t ...... retroviral resistance testing.
@ast
Human immunodeficiency virus t ...... retroviral resistance testing.
@en
type
label
Human immunodeficiency virus t ...... retroviral resistance testing.
@ast
Human immunodeficiency virus t ...... retroviral resistance testing.
@en
prefLabel
Human immunodeficiency virus t ...... retroviral resistance testing.
@ast
Human immunodeficiency virus t ...... retroviral resistance testing.
@en
P2093
P2860
P1476
Human immunodeficiency virus t ...... retroviral resistance testing.
@en
P2093
A V Savara
J Martinez-Picado
M P De Pasquale
R T D'Aquila
P2860
P304
P407
P577
1999-09-01T00:00:00Z